Literature DB >> 10531210

Identification of a Clostridium perfringens enterotoxin region required for large complex formation and cytotoxicity by random mutagenesis.

J F Kokai-Kun1, K Benton, E U Wieckowski, B A McClane.   

Abstract

Clostridium perfringens enterotoxin (CPE), a single polypeptide of 319 amino acids, has a unique multistep mechanism of action. In the first step, CPE binds to claudin proteins and/or a 50-kDa eukaryotic membrane protein receptor, forming a small ( approximately 90-kDa) complex. This small complex apparently then associates with a 70-kDa eukaryotic membrane protein, resulting in formation of a large complex that induces the onset of membrane permeability alterations. To better define the boundaries of CPE functional regions and to identify specific amino acid residues involved in various steps of CPE action, in this study we subjected the cloned cpe gene to random mutagenesis in XL-1 Red strains of Escherichia coli. Seven CPE random mutants with reduced cytotoxicity for Vero cells were phenotypically characterized for the ability to complete each step in CPE action. Five of these seven recombinant CPE (rCPE) random mutants (G49D, S59L, R116S, R137G, and S167P) exhibited binding characteristics similar to those of rCPE or native CPE, while the Y310C and W226Stop mutants showed reduced binding and no binding, respectively, to brush border membranes. Interestingly, two completely nontoxic mutants (G49D and S59L) were able to bind and form small complex but they did not mediate any detectable large complex formation. Another strongly attenuated mutant, R116S, formed reduced amounts of an anomalously migrating large complex. Collectively, these results provide further support for large complex formation being an essential step in CPE action and also identify the CPE region ranging from residues approximately 45 to 116 as important for large complex formation. Finally, we also report that limited removal of extreme N-terminal CPE sequences, which may occur in vivo during disease, stimulates cytotoxic activity by enhancing large complex formation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531210      PMCID: PMC96936     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Evaluation and improvement of multiple sequence methods for protein secondary structure prediction.

Authors:  J A Cuff; G J Barton
Journal:  Proteins       Date:  1999-03-01

2.  A hydrophobic form of the small-intestinal sucrase-isomaltase complex.

Authors:  H Sigrist; P Ronner; G Semenza
Journal:  Biochim Biophys Acta       Date:  1975-10-17

3.  Primary action of Clostridium perfringens type A enterotoxin on HeLa and Vero cells in the absence of extracellular calcium: rapid and characteristic changes in membrane permeability.

Authors:  M Matsuda; K Ozutsumi; H Iwahashi; N Sugimoto
Journal:  Biochem Biophys Res Commun       Date:  1986-12-15       Impact factor: 3.575

4.  Characterization of membrane permeability alterations induced in Vero cells by Clostridium perfringens enterotoxin.

Authors:  B A McClane; J L McDonel
Journal:  Biochim Biophys Acta       Date:  1980-08-14

5.  Trypsin activation of enterotoxin from Clostridium perfringens type A: fragmentation and some physicochemical properties.

Authors:  P E Granum; J R Whitaker; R Skjelkvåle
Journal:  Biochim Biophys Acta       Date:  1981-05-29

6.  Isolation and function of a Clostridium perfringens enterotoxin fragment.

Authors:  Y Horiguchi; T Akai; G Sakaguchi
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

7.  Divalent cation involvement in the action of Clostridium perfringens type A enterotoxin. Early events in enterotoxin action are divalent cation-independent.

Authors:  B A McClane; A P Wnek; K I Hulkower; P C Hanna
Journal:  J Biol Chem       Date:  1988-02-15       Impact factor: 5.157

8.  Preliminary evidence that Clostridium perfringens type A enterotoxin is present in a 160,000-Mr complex in mammalian membranes.

Authors:  A P Wnek; B A McClane
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

9.  Protective effects of osmotic stabilizers on morphological and permeability alterations induced in Vero cells by Clostridium perfringens enterotoxin.

Authors:  B A McClane; J L McDonel
Journal:  Biochim Biophys Acta       Date:  1981-03-06

10.  Osmotic stabilizers differentially inhibit permeability alterations induced in Vero cells by Clostridium perfringens enterotoxin.

Authors:  B A McClane
Journal:  Biochim Biophys Acta       Date:  1984-10-17
View more
  24 in total

1.  Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin.

Authors:  Ganes Chakrabarti; Xin Zhou; Bruce A McClane
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

2.  Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity.

Authors:  James G Smedley; Juliann Saputo; Jacquelyn C Parker; Mariano E Fernandez-Miyakawa; Susan L Robertson; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

3.  Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin.

Authors:  Susan L Robertson; James G Smedley; Bruce A McClane
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

4.  Crystal structure of Clostridium perfringens enterotoxin displays features of beta-pore-forming toxins.

Authors:  Kengo Kitadokoro; Kousuke Nishimura; Shigeki Kamitani; Aya Fukui-Miyazaki; Hirono Toshima; Hiroyuki Abe; Yoichi Kamata; Yoshiko Sugita-Konishi; Shigeki Yamamoto; Hajime Karatani; Yasuhiko Horiguchi
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

5.  Potential Therapeutic Effects of Mepacrine against Clostridium perfringens Enterotoxin in a Mouse Model of Enterotoxemia.

Authors:  Mauricio A Navarro; Archana Shrestha; John C Freedman; Juliann Beingesser; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

Review 6.  Recent trends and advances in microbe-based drug delivery systems.

Authors:  Pravin Shende; Vasavi Basarkar
Journal:  Daru       Date:  2019-08-02       Impact factor: 3.117

7.  Clostridium perfringens enterotoxin interacts with claudins via electrostatic attraction.

Authors:  Jun Kimura; Hiroyuki Abe; Shigeki Kamitani; Hirono Toshima; Aya Fukui; Masami Miyake; Yoichi Kamata; Yoshiko Sugita-Konishi; Shigeki Yamamoto; Yasuhiko Horiguchi
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

Review 8.  Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers.

Authors:  Yosuke Hashimoto; Kiyohito Yagi; Masuo Kondoh
Journal:  Pflugers Arch       Date:  2016-09-15       Impact factor: 3.657

Review 9.  Bacteria in cancer therapy: a novel experimental strategy.

Authors:  S Patyar; R Joshi; D S Prasad Byrav; A Prakash; B Medhi; B K Das
Journal:  J Biomed Sci       Date:  2010-03-23       Impact factor: 8.410

10.  Cysteine-scanning mutagenesis supports the importance of Clostridium perfringens enterotoxin amino acids 80 to 106 for membrane insertion and pore formation.

Authors:  Jianwu Chen; James R Theoret; Archana Shrestha; James G Smedley; Bruce A McClane
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.